Physician Assistant, Medical · Austin, TX
NPI
1073842696
Since 2009
Specialty
Physician Assistant, Medical
Code 363AM0700X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
11410 Jollyville Rd Ste 1101
Austin, TX, 78759
Phone (512) 231-1444
Groups this clinician bills Medicare through
Medicare paid, 2024
$110K
5,975 services
Medicare patients, 2024
466
Average age 76
Drug cost, 2024
$510K
2,592 prescriptions
Company payments, 2025
$2,376
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Danielle B Manes was code J0585 (injection, onabotulinumtoxina, 1 unit), 2,700 times for 17 patients. In total Danielle B Manes billed 5,975 services in 30 codes, and Medicare paid $110K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 2,700 | 17 | $4.98 | $13K |
| 81003 Clinical Chemistry | Office | 773 | 429 | $2.19 | $1,694 |
| 51798 Ultrasound - Nonspecific | Office | 746 | 422 | $8.41 | $6,272 |
| 99214 Office E&M - Established | Office | 597 | 332 | $76.94 | $46K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 425 | 299 | $9.98 | $4,241 |
| 99213 Office E&M - Established | Office | 161 | 141 | $55.00 | $8,855 |
| 99459 Office/Outpatient Services | Office | 75 | 67 | $14.27 | $1,071 |
| 95972 Electrical Nerve Conductivity | Office | 58 | 39 | $34.95 | $2,027 |
| 99204 Office E&M - New | Office | 50 | 50 | $100.55 | $5,027 |
| 52000 Cystourethroscopy | Office | 42 | 38 | $149.67 | $6,286 |
| 51701 Other Organ Systems | Office | 32 | 29 | $29.62 | $948 |
| 52287 Cystourethroscopy | Office | 24 | 19 | $231.02 | $5,545 |
| 36415 Venipuncture Blood Collection | Office | 18 | 18 | $8.65 | $156 |
| 51700 Other Organ Systems | Office | 15 | 11 | $42.94 | $644 |
By year: 2022 $99K for 3,359 services; 2023 $120K for 5,388 services; 2024 $110K for 5,975 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 773 | 429 | $2.19 | $1,694 |
| 36415 Venipuncture Blood Collection | 18 | 18 | $8.65 | $156 |
Medicare prescription drug claims, 2024
In 2024, the drug Danielle B Manes prescribed most often to Medicare patients was Gemtesa (Vibegron), with 298 prescriptions and refills. In total Danielle B Manes wrote 2,592 Medicare prescriptions that cost $510K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gemtesa Vibegron | 298 | 500 | 79 | $231K |
| Estradiol Generic | 278 | 735 | 151 | $14K |
| Myrbetriq Mirabegron | 178 | 329 | 65 | $145K |
| Tamsulosin Hcl Generic | 178 | 321 | 73 | $2,386 |
| Cephalexin Generic | 172 | 272 | 81 | $1,636 |
| Nitrofurantoin Nitrofurantoin Macrocrystal | 137 | 277 | 49 | $5,060 |
| Methenamine Hippurate Generic | 105 | 175 | 33 | $7,267 |
| Solifenacin Succinate Generic | 101 | 187 | 30 | $4,285 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 98 | 102 | 86 | $1,384 |
| Progesterone Progesterone, Micronized | 81 | 168 | 25 | $5,523 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 70 | 167 | 26 | $1,586 |
| Fluconazole Generic | 67 | 71 | 40 | $440 |
| Amitriptyline Hcl Generic | 55 | 99 | 14 | $496 |
| Mirabegron Er Mirabegron | 47 | 110 | 26 | $34K |
| Osphena Ospemifene | 44 | 56 | Under 11 | $13K |
Brand drugs: - claims; generic drugs: 1,971 claims; opioid claims: 14.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Danielle B Manes $2,376 ($2,376 in general payments such as food, travel and fees) from 15 companies. The largest payer was Sumitomo Pharma America, Inc. with $811.
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. 4506.T | 54 | $811 |
| Medtronic, Inc. MDT | 18 | $645 |
| Abbvie Inc. ABBV | 11 | $268 |
| Dendreon Pharmaceuticals LLC | 3 | $102 |
| Ferring Pharmaceuticals Inc. | 4 | $97.41 |
| Urogen Pharma, Inc. URGN | 4 | $81.28 |
| Endo USA, Inc. | 3 | $77.91 |
| Coloplast Corp | 2 | $56.41 |
| Janssen Biotech, Inc. JNJ | 3 | $55.75 |
| Pfizer Inc. PFE | 2 | $48.4 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.